Showing results (651-660 of 7,984) with videos related to
Sort By:
Pageof 799
Current Medicinal Chemistry|October 3, 1998
Octanol-water partition: searching for predictive modelsP Buchwald, N BodorCurrent Medicinal Chemistry|July 21, 1998
The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applicationsG Dannhardt, B K KohlCurrent Medicinal Chemistry|July 21, 1998
Novel benztropine [3a-(diphenylmethoxy)tropane] analogs as probes for the dopamine transporterA H Newman, G E AgostonCurrent Medicinal Chemistry|March 23, 2004
Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapyT L Underiner, B Ruggeri, D E GingrichCurrent Medicinal Chemistry|March 23, 2004
4-thiophenoxy-N-(3,4,5-trialkoxyphenyl)pyrimidine-2-amines as potent and selective inhibitors of the T-cell tyrosine kinase p56lckD F C Moffat, R A Allen, S E Rapecki, et al.Current Medicinal Chemistry|March 23, 2004
SNP analysis combined with protein structure prediction defines structure-functional relationships in cancer related cytochrome P450 estrogen metabolismIgor F Tsigelny, Vladimir Kotlovyi, Linda WassermanCurrent Medicinal Chemistry|March 23, 2004
Improving the understanding of human genetic diseases through predictions of protein structures and protein-protein interaction sitesHuan-Xiang ZhouCurrent Medicinal Chemistry|April 14, 2004
Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictorP Grieco, P Rovero, E NovellinoCurrent Medicinal Chemistry|April 14, 2004
The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidateT D Bradshaw, A D WestwellCurrent Medicinal Chemistry|April 14, 2004
Biochemistry, biology, and pharmacology of cyclic adenosine diphosphoribose (cADPR)Andreas H GusePageof 799